ERVIN GRAVES STRATEGY GROUP, LLC for EMERGENT BIOSOLUTIONS INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Disaster Planning/Emergencies DIS
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government. Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
| Lobbyist | Covered position, as disclosed |
|---|---|
| MADELEINE COLAIEZZI | — |
| JAMES L ERVIN | Chairman & CEO |
| COLBY MILLER | — |
Budget/Appropriations BUD
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government. Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
| Lobbyist | Covered position, as disclosed |
|---|---|
| MADELEINE COLAIEZZI | — |
| JAMES L ERVIN | Chairman & CEO |
| COLBY MILLER | — |
Homeland Security HOM
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government. Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
| Lobbyist | Covered position, as disclosed |
|---|---|
| MADELEINE COLAIEZZI | — |
| JAMES L ERVIN | Chairman & CEO |
| COLBY MILLER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.